Vaxcell-Bio Therapeutics Co., Ltd. (KOSDAQ:323990)
South Korea
· Delayed Price · Currency is KRW 8,350.00
+230.00 (2.83%)
Apr 1, 2025, 3:30 PM KST
Vaxcell-Bio Therapeutics Market Cap
Vaxcell-Bio Therapeutics has a market cap or net worth of 191.99 billion as of April 1, 2025. Its market cap has decreased by -56.51% in one year.
Market Cap
191.99B
Enterprise Value
158.21B
Revenue
1.90B
Ranking
n/a
PE Ratio
n/a
Stock Price
8,350.00
Market Cap Chart
Since September 22, 2020, Vaxcell-Bio Therapeutics's market cap has increased from 160.24B to 191.99B, an increase of 19.82%. That is a compound annual growth rate of 4.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 31, 2025 | 186.70B | -22.15% |
| Dec 30, 2024 | 239.82B | -53.54% |
| Dec 28, 2023 | 516.20B | -0.71% |
| Dec 29, 2022 | 519.87B | -21.31% |
| Dec 30, 2021 | 660.68B | -73.75% |
| Dec 30, 2020 | 2,517.20B | 1,470.89% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Electronics | 396.83T |
| SK hynix | 137.33T |
| LG Energy Solution | 83.30T |
| Samsung Biologics | 74.66T |
| Hyundai Motor Company | 44.69T |
| Celltrion | 38.03T |
| Kia Corporation | 37.52T |
| KB Financial Group | 29.19T |